[go: up one dir, main page]

IL133076A - Solubilized sertraline pharmaceutical compositions - Google Patents

Solubilized sertraline pharmaceutical compositions

Info

Publication number
IL133076A
IL133076A IL13307698A IL13307698A IL133076A IL 133076 A IL133076 A IL 133076A IL 13307698 A IL13307698 A IL 13307698A IL 13307698 A IL13307698 A IL 13307698A IL 133076 A IL133076 A IL 133076A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
sertraline
solubilized
solubilized sertraline
pharmaceutical
Prior art date
Application number
IL13307698A
Other versions
IL133076A0 (en
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL133076(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL133076A0 publication Critical patent/IL133076A0/en
Publication of IL133076A publication Critical patent/IL133076A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13307698A 1997-07-01 1998-06-15 Solubilized sertraline pharmaceutical compositions IL133076A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (2)

Publication Number Publication Date
IL133076A0 IL133076A0 (en) 2001-03-19
IL133076A true IL133076A (en) 2003-12-10

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13307698A IL133076A (en) 1997-07-01 1998-06-15 Solubilized sertraline pharmaceutical compositions

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200201617T2 (en) 1999-12-23 2002-10-21 Pfizer Products Inc. Pharmaceutical compositions that provide enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
US20100105638A1 (en) * 2007-03-12 2010-04-29 Kerstin Den-Braven Cosmetic compositions
AU2010285740C1 (en) 2009-08-19 2016-03-17 Eisai R&D Management Co., Ltd. Quinoline derivative-containing pharmaceutical composition
WO2011081118A1 (en) * 2009-12-29 2011-07-07 興和株式会社 Pharmaceutical composition for oral administration
WO2011081117A1 (en) * 2009-12-29 2011-07-07 興和株式会社 Solid pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process
CN114894736B (en) * 2022-05-20 2025-03-21 中化地质矿山总局地质研究院 A method for determining nitrate in chloride-type brine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
NO996520L (en) 2000-02-29
ZA985708B (en) 2000-01-10
HRP980377A2 (en) 1999-04-30
CO4940495A1 (en) 2000-07-24
AU7544898A (en) 1999-01-25
IS5260A (en) 1999-11-19
JP2000514100A (en) 2000-10-24
HN1998000102A (en) 1999-01-08
KR100366373B1 (en) 2003-01-14
UA67741C2 (en) 2004-07-15
TR199903297T2 (en) 2000-07-21
PA8454301A1 (en) 2000-09-29
TW550087B (en) 2003-09-01
IL133076A0 (en) 2001-03-19
PE97199A1 (en) 1999-10-05
CA2290974A1 (en) 1999-01-14
AR015917A1 (en) 2001-05-30
HUP0002236A2 (en) 2003-08-28
AU742535B2 (en) 2002-01-03
BR9810739A (en) 2000-09-12
EA199900962A1 (en) 2000-08-28
AP9801280A0 (en) 1998-06-30
DZ2548A1 (en) 2003-02-08
AR040280A2 (en) 2005-03-23
PL337804A1 (en) 2000-09-11
SK181099A3 (en) 2000-07-11
EP0999829A1 (en) 2000-05-17
TNSN98124A1 (en) 2005-03-15
CN1261794A (en) 2000-08-02
EA002481B1 (en) 2002-06-27
KR20010013365A (en) 2001-02-26
NO996520D0 (en) 1999-12-28
OA11243A (en) 2003-07-24
MA24587A1 (en) 1998-12-31
AR040279A2 (en) 2005-03-23
AP1192A (en) 2003-07-23
ID23429A (en) 2000-04-20
CA2290974C (en) 2004-04-27
WO1999001120A1 (en) 1999-01-14
UY25071A1 (en) 2000-12-29
HUP0002236A3 (en) 2003-12-29
BG103918A (en) 2000-07-31
YU68299A (en) 2002-06-19

Similar Documents

Publication Publication Date Title
GB9727053D0 (en) Pharmaceutical compositions
EG24118A (en) Pharmaceutical compositions
GB9706089D0 (en) Pharmaceutical composition
GB9610359D0 (en) Pharmaceutical compositions
GB9717444D0 (en) Pharmaceutical composition
IL131917A0 (en) Pharmaceutical compositions
IL131995A0 (en) Gastric-retained pharmaceutical compositions
IL133076A (en) Solubilized sertraline pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
ZA9811532B (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB9610136D0 (en) Pharmaceutical compositions
ZA982117B (en) Pharmaceutical compositions
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition
GB9714081D0 (en) Pharmaceutical compositions
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
GB9710527D0 (en) Pharmaceutical compositions
GB9714328D0 (en) Pharmaceutical compositions
GB9722066D0 (en) Pharmaceutical compositions
GB9825499D0 (en) Pharmaceutical compositions
GB9725563D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees